Literature DB >> 15959652

Men's decision-making about predictive BRCA1/2 testing: the role of family.

N Hallowell1, A Ardern-Jones, R Eeles, C Foster, A Lucassen, C Moynihan, M Watson.   

Abstract

Men who have a family history of breast and/or ovarian cancer may be offered a predictive genetic test to determine whether or not they carry the family specific BRCA1/2 mutation. Male carriers may be at increased risk of breast and prostate cancers. Relatively little is known about at-risk men's decision-making about BRCA1/2 testing. This qualitative study explores the influences on male patients' genetic test decisions. Twenty-nine in-depth interviews were undertaken with both carrier and noncarrier men and immediate family members (17 male patients, 8 female partners, and 4 adult children). These explored family members' experiences of cancer and genetic testing, decision-making about testing, family support, communication of test results within the family, risk perception and risk management. Implicit influences on men's testing decisions such as familial obligations are examined. The extent to which other family members--partners and adult children--were involved in testing decisions is also described. It is demonstrated that mothers of potential mutation carriers not only perceive themselves as having a right to be involved in making this decision, but also were perceived by their male partners as having a legitimate role to play in decision-making. There was evidence that (adult) children were excluded from the decision-making, and some expressed resentment about this. The implications of these findings for the practice of genetic counseling are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15959652     DOI: 10.1007/s10897-005-0384-3

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  24 in total

1.  Factors associated with decisions about clinical BRCA1/2 testing.

Authors:  K Armstrong; K Calzone; J Stopfer; G Fitzgerald; J Coyne; B Weber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-11       Impact factor: 4.254

2.  Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway.

Authors:  Trine Levin Bodd; Jon Reichelt; Ketil Heimdal; Pal Moller
Journal:  J Genet Couns       Date:  2003-10       Impact factor: 2.537

Review 3.  Genetic testing for breast and ovarian cancer susceptibility: a family experience.

Authors:  Marcia Van Riper; Wendy C McKinnon
Journal:  J Midwifery Womens Health       Date:  2004 May-Jun       Impact factor: 2.388

4.  Factors Influencing Men's Interest in Gene Testing for Prostate Cancer Susceptibility.

Authors:  Duane D Culler; Judy Silberg; Lauren Vanner-Nicely; Joy L Ware; Colleen Jackson-Cook; Joann Bodurtha
Journal:  J Genet Couns       Date:  2002-10       Impact factor: 2.537

5.  Cancer risks in BRCA2 mutation carriers.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1999-08-04       Impact factor: 13.506

6.  Men in breast cancer families: a preliminary qualitative study of awareness and experience.

Authors:  M F McAllister; D G Evans; W Ormiston; P Daly
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

7.  Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network.

Authors:  C Julian-Reynier; H Sobol; C Sévilla; C Noguès; P Bourret
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

8.  Predictive testing for BRCA1 and 2 mutations: a male contribution.

Authors:  P A Daly; C Nolan; A Green; W Ormiston; N Cody; T McDevitt; B O'hIci; D Byrne; E McDermott; D N Carney; N O'Higgins; D E Barton
Journal:  Ann Oncol       Date:  2003-04       Impact factor: 32.976

9.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching.

Authors:  N Hallowell; C Foster; A Ardern-Jones; R Eeles; V Murday; M Watson
Journal:  Genet Test       Date:  2002
View more
  31 in total

1.  Stigmatization and male identity: Norwegian males' experience after identification as BRCA1/2 mutation carriers.

Authors:  Nina Strømsvik; Målfrid Råheim; Nina Oyen; Lars Fredrik Engebretsen; Eva Gjengedal
Journal:  J Genet Couns       Date:  2010-03-20       Impact factor: 2.537

2.  The Quality of Genetic Counseling and Connected Factors as Evaluated by Male BRCA1/2 Mutation Carriers in Finland.

Authors:  Outi Kajula; Maria Kääriäinen; Jukka S Moilanen; Helvi Kyngäs
Journal:  J Genet Couns       Date:  2015-09-29       Impact factor: 2.537

3.  The role of genetics in the provision of essential public health services.

Authors:  Grace Wang; Carolyn Watts
Journal:  Am J Public Health       Date:  2007-02-28       Impact factor: 9.308

4.  Decision-making about inherited cancer risk: exploring dimensions of genetic responsibility.

Authors:  Holly Etchegary; Fiona Miller; Sonya deLaat; Brenda Wilson; June Carroll; Mario Cappelli
Journal:  J Genet Couns       Date:  2009-03-18       Impact factor: 2.537

5.  Communicating genetic information in the family: enriching the debate through the notion of integrity.

Authors:  Paula Boddington; Maggie Gregory
Journal:  Med Health Care Philos       Date:  2008-04-09

6.  Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.

Authors:  Reshma Jagsi; Kent A Griffith; Allison W Kurian; Monica Morrow; Ann S Hamilton; John J Graff; Steven J Katz; Sarah T Hawley
Journal:  J Clin Oncol       Date:  2015-04-06       Impact factor: 44.544

7.  Perceived intrafamily melanoma risk communication.

Authors:  Lois J Loescher; Janice D Crist; Leilani A C L Siaki
Journal:  Cancer Nurs       Date:  2009 May-Jun       Impact factor: 2.592

8.  On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children.

Authors:  Beth N Peshkin; Tiffani A Demarco; Kenneth P Tercyak
Journal:  Fam Cancer       Date:  2009-07-17       Impact factor: 2.375

9.  Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children.

Authors:  Tiffani A DeMarco; Beth N Peshkin; Heiddis B Valdimarsdottir; Andrea F Patenaude; Katherine A Schneider; Kenneth P Tercyak
Journal:  J Genet Couns       Date:  2008-02-21       Impact factor: 2.537

10.  Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.

Authors:  E Ormondroyd; C Moynihan; M Watson; C Foster; S Davolls; A Ardern-Jones; R Eeles
Journal:  J Genet Couns       Date:  2007-05-11       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.